DIAGEO plc (DEO): what the price assumes
boothcheck covers DIAGEO plc (DEO) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-25.
Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/DEO
Headline
| Field | Value |
|---|---|
| Ticker | DEO |
| Company | DIAGEO plc |
| Sector / Industry | Consumer Defensive |
| Current price | $89.19/sh |
| Composition | North America 31% / Europe 29% / Asia Pacific 22% / Latin America and Caribbean 9% / Africa 10% / Corporate and other 0% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin (value-band context) | 7.3% |
| Operating margin today | 15.5% |
| Margin compression (value-band) | -8.2pp |
| Multiple paid | 16x operating income |
The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.
How unusual the bet is: n/a
Valuation X-Ray
The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 1.93x | 5 | expensive |
| Earnings | 1.95x | 3 | expensive |
| Relative | 1.13x | 3 | expensive |
| Growth | 0.88x | 4 | justifies |
Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.5%); the inversion above states its own rate.
Per-Model Detail (n=15)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $565.54 | 0.16x | yes | FCF base $12.8B, growth 4% (input: historical growth), terminal g 4.0%, WACC 7.5%, 5yr projection |
| DCF Exit Multiple | Growth | $158.82 | 0.56x | yes | Exit EV/EBITDA: 15.7x / 17.7x / 19.7x (bear / base = today's held flat / bull), 5yr |
| Relative Valuation | Relative | $79.18 | 1.13x | yes | P/E 22x (static sector reference · 2026-04), scenarios: 18.4x / 22.0x / 25.6x (bear / base = reference held flat / bull), EV/EBITDA 14x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | $74.16 | 1.20x | yes | Stage 1: -15% for 5yr, Stage 2: 3.5% perpetual |
| Simple Excess Return | Asset | $45.12 | 1.98x | yes | BV/sh $22.52, ROE (TTM) 18.5%, ke 9.3% |
| Two-Stage Excess Return | Asset | $63.09 | 1.41x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $66.26 | 1.35x | yes | Rev $28.0B, growth 4% (input: historical growth; tapered), Terminal P/S: 1.6x / 1.9x / 2.3x (bear / base = today's held flat / bull, cap 8x) |
| Growth-Adjusted P/E | Relative | — | — | no | — |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $31.54 | 2.83x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $4.36B × (1−28%) / WACC 7.5% → EPV (no growth) |
| Residual Income | Asset | $62.27 | 1.43x | yes | BV $22.52 + 5yr PV of (ROE (TTM) 18.5% − Kₑ 9.3%) × BV; BV grows 8.8%/yr |
| Graham Number | Asset | $46.33 | 1.93x | yes | √(22.5 × EPS $4.24 × BVPS $22.52) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $62.65 | 1.42x | yes | EBITDA $4.33B × sector EV/EBITDA 14.0x |
| FCF Yield | Earnings | $191.29 | 0.47x | yes | FCF $12850.0M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | $3.55 | 25.12x | yes | EPS $4.24 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median) |
| ROIC-Justified P/B | Asset | $25.80 | 3.46x | yes | BV $22.52 × (ROIC 8.6% / WACC 7.5%) |
| P/Sales Sector | Relative | $91.97 | 0.97x | yes | Revenue $27.96B × sector P/S 2.0x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | $45.79 | 1.95x | yes | EPS $4.24 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $21.3b |
| Net debt / NOPAT (after-tax) | 6.85x |
| Net debt / operating income (pre-tax) | 4.91x |
| Interest coverage | 3.8x |
| Share count CAGR (buyback) | -1.3% |
| Burning cash | no |
Bullet Takeaways
- Revenue is spread deliberately wide across the map, North America at 31% of it, Europe 29%, Asia Pacific 22%, Africa 10% and Latin America and the Caribbean 9%, so no single market decides the year.
- The whole category is in a demand trough and the peers show it: STZ revenue fell 10.2% over the trailing year, TAP 5.1% and SAM 4.6%, and both TAP and SAM ran negative operating margins.
- Full-year results are due August 13, 2026, and with net borrowings near $21.3 billion against a $46.2 billion market value, the pace of debt reduction is the line to read first.
Bull Case
The market has already decided this is a business in decline, and it has priced accordingly. At $83.09 the shares sit below the level that even a 5% annual fall in operating profit would warrant, worked out at a 7% cost of capital across a five year stage. That is not a demanding bar for a holder to clear. It does not require growth. It requires the profit stream to shrink more slowly than the price assumes, or not at all.
What sits underneath is a business with unusually few single points of failure. North America contributes 31% of revenue, Europe 29%, Asia Pacific 22%, Africa 10%, and Latin America and the Caribbean 9%. Very few consumer companies of this size are spread that evenly, and the spread matters more than usual in a year when the weakness in beverage alcohol has been regional rather than universal. A soft American on-trade and a soft Chinese gifting season do not arrive on the same schedule.
Distilled spirits also carry a structural advantage most consumer categories lack, which is that the inventory takes years to make. BF-B states the mechanism plainly in its own filing: "Whiskeys, certain tequilas, rums, and some other distilled spirits must be aged. Because we must produce these distilled spirits years in advance to meet projected future demand", the supply on offer in any given year was committed long before anyone knew what demand would look like. That cuts against a producer in a downturn. It is also why a well-funded newcomer cannot simply appear at scale in an aged category: the barrier is brand plus barrel stock, and both take a decade to assemble. BF-B lists what actually decides the purchase, and none of it is capacity: "Brand recognition, brand provenance, quality of product and packaging, availability, flavor profile, and price affect consumers' choices among competing brands in our industry."
Two more things favour the holder here. The share count has been falling about 1.3% a year over the past four years, which is repurchase money spent rather than repurchase authority announced. And against the sector, the peer-multiple methods land essentially on today's price, meaning the shares are not carrying a premium that has to be defended before anything else can go right. Rivals are doing the same repair work from worse positions: STZ tells its own holders about "our repositioned wine and spirits portfolio that we believe is positioned for long-term growth, focus on operational efficiencies and tactical measures, and commitment to improving margins", which is what a company says when the previous plan did not work.
Bear Case
Beverage alcohol is in the down leg of a cycle, and the peer numbers say so without needing much interpretation. STZ revenue fell 10.2% over the trailing year, TAP fell 5.1%, SAM fell 4.6%, and BF-B managed growth of just 0.5%. Two of those four could not hold a positive operating margin at all: TAP ran negative 17.9% and SAM negative 3.8%. That is what happens when an industry built its cost base and its capacity for volume growth, and the volume growth stops.
The demand story is not obviously a passing one either. STZ files the reasons alongside its risk factors, naming "moderation, and betterment trends, pricing, perceived value, branding, marketing, and reputational considerations" as pressures on the whole category. Moderation is the industry's word for people drinking less, and it is the kind of shift that shows up slowly, does not reverse on a good quarter, and lands hardest on the mainstream volume brands rather than on the very top of the range.
Competition is broadening at the same time. BF-B describes the encroachment directly: "the entrance of both traditional beer and soft drink companies into the ready-to-drink market and the entrance of both beer and spirits companies into the cannabis market - expanding the potential for competition in the spirits market from various sectors of the consumer goods industry." Meanwhile capacity keeps arriving. STZ says it will "invest in the next phase of modular capacity additions" even after a year of double-digit revenue decline, which is the classic late-cycle behaviour: plants ordered in the good years finish in the bad ones.
Then there is who holds the pricing power in the channel. BF-B puts it as bluntly as a filing allows: "If the buying power of these large retail customers continues to increase, it could negatively affect our financial results." Tariffs press the same margin from the other side, and again the peer filing is explicit that the cost lands somewhere: "to the extent we absorb the costs of tariffs and do not pass them through to our customers, higher cost of goods sold and lower gross profit and margins". For any spirits business selling across borders, that is an arithmetic question rather than a headline risk.
The balance sheet is where a soft cycle stops being an inconvenience. Net borrowings stand near $21.3 billion, and obligations of that size do not adjust themselves to a soft demand environment. The company carries them against a market value of $46.2 billion, which makes the equity a levered claim on a profit stream currently heading the wrong way. What bounds the downside is that roughly $5.4 billion of equity stakes sit outside the operating business, close to 12% of market value, and those hold their worth whatever the trading business does over the next two years. That is a floor under the price, not a rescue of the thesis. A bull deserves the concession that the price already assumes shrinkage; the bear's point is that a leveraged balance sheet turns a longer trough into a capital allocation problem rather than merely a profit one.
Valuation
Today's price does not ask the business to grow. It asks it to decline more slowly than the market currently assumes. Inverted at a 7% cost of capital over a five year stage, the quote sits below the level that even a 5% annual decline in operating profit would warrant. For a company of this size, with brands built over a century and a presence in five regions, that is an unusual place to be trading.
The methods behind that do not line up neatly, and the disagreement is the useful part. Peer multiples land essentially on today's price, which reads as ordinary rather than cheap. The cash-flow methods reach well past it, because they credit the profit stream continuing at close to its recent pace. The book-value and earnings-power lenses land below the price, which is what happens to a company whose most valuable assets are brands carried at historical cost rather than plants carried at replacement value. One dividend-based approach is the most telling of the set: it arrives at today's price while assuming the stream it discounts contracts 15% a year for five years before settling into low single-digit growth. That is the level of pessimism the quote already contains.
Set against the sector, the position is mid-pack rather than cheap-because-broken. STZ still converted a 29.9% operating margin on revenue that fell 10.2%, and BF-B a 19.7% margin on revenue that barely moved. TAP and SAM both ran negative operating margins for the year. The question the price is really posing is which of those two groups this company comes to resemble as the cycle plays out, and the geographic spread across North America at 31% of revenue, Europe at 29% and Asia Pacific at 22% is the main reason to expect the first.
Net borrowings near $21.3 billion are the constraint on everything else. They set the order of priority for cash: interest first, dividend second, buybacks last, and buybacks have still been running hard enough to take the share count down about 1.3% a year over four years. Against that sits roughly $5.4 billion of equity holdings outside the operating business, close to 12% of the market value, which is real and separable rather than an accounting artifact. The distance between the borrowings and those holdings is where the next two years of capital allocation gets decided.
Catalysts
The pre-close document landed first. Diageo published its aide memoire for fiscal 2026 on July 10, 2026, the note that resets conventions and comparatives before the numbers arrive. The results themselves are scheduled for August 13, 2026, covering the year that ended in June. Before that, a third-quarter trading statement was issued on May 6, 2026.
Capital is still going into supply while demand is soft. A new brewery at Littleconnell opened on May 11, 2026 as part of a commitment approaching one billion euro in Ireland, and a new manufacturing facility in Alabama opened on April 21, 2026. Both are the sort of spending that lands in the accounts years ahead of the volume it is built to serve, which is exactly the timing mismatch the aged-spirits model imposes on everyone in it.
The portfolio is being trimmed at the same edge. The sale of Sheridan's completed on January 30, 2026, and in March the Indian subsidiary announced a full divestiture of its stake in Royal Challengers Sports. Neither disposal is large on its own. Together they point at a preference for fewer and bigger things, which is the ordinary corporate response to a category that has stopped growing on its own.
Peer Cohorts (Per Segment, With Filing Citations)
Core business (reported)
- BUD (Anheuser-Busch InBev SA/NV)
- FY2025 20-F: Table of Contents For a discussion of changes in revenue, see "Item 5. Operating and Financial Review-E. Results of Operations-Year Ended 31 December 2025 Compared to the Year Ended 31 December 2024-Revenue" of this Form 20-F and "Item 5. Operating and Financial Review-E. Results of Operations-Year Ended 31 December…
- FY2025 20-F: …we are well-placed to address changing consumer needs in the various categories (above core, core and value) within any given market. 4. COMPETITION We believe our largest competitors are Heineken, China Resources, and Carlsberg based on information from IWSR as of January 2026. Historically, brewing was a local…
- ABEV (AMBEV S.A.)
- FY2025 20-F: …customer service. Consolidation has significantly increased the capital base and geographic reach of our competitors in some of the markets in which we operate. Concurrently, competition in the beverage industry is expanding and the market is becoming more fragmented, complex and sophisticated as consumer preferences…
- FY2025 20-F: …them could adversely affect the sale and consumption of our products and harm our business, results of operations, cash flows or financial condition to the extent consumers and customers change their purchasing patterns. Key brand names are used by us, our subsidiaries, associates and joint ventures, and licensed to…
- TAP (MOLSON COORS BEVERAGE CO)
- FY2025 10-K: …In the U.S. and Canada, we compete most directly with Anheuser-Busch InBev SA/NV ("ABI") and Constellation Brands, Inc., but we also compete with imports and other providers of craft beer and flavored malt beverages. In the European countries where we currently operate, our primary competitors are Heineken, Asahi,…
- FY2025 10-K: …over the years becoming an increasingly consolidated global beer market. For many years, the industry operated primarily on local presence with modest international expansion achieved through export, license and partnership arrangements. In contrast, it has now become increasingly complex and competitive as the…
- SAM (THE BOSTON BEER COMPANY, INC.)
- FY2025 10-K: …significantly greater resources than the Company. This competitive environment may affect the Company's overall performance within the Beyond beer and Traditional beer categories. As the market continues to consolidate, the Company believes that companies that are well-positioned in terms of brand equity, marketing…
- FY2025 10-K: Company anticipates competition will remain strong as existing beverage companies continue adding more SKUs and styles. The potential for growth in the sales of flavored malt beverages, hard seltzers, domestic beers, imported beers and spirits RTDs is expected to increase the competition in the market for Beyond beer…
- STZ (CONSTELLATION BRANDS, INC.)
- FY2025 10-K: …Officer. The business segments reflect how our operations are managed, how resources are allocated, how operating performance is evaluated by senior management, and the structure of our internal financial reporting. Long-lived tangible assets and total asset information by segment is not provided to, or reviewed by,…
- FY2025 10-K: …We perform ongoing credit evaluations of our customers' financial position, and management is of the opinion that any risk of significant loss is reduced due to the diversity of our customers and geographic sales area. 22. BUSINESS SEGMENT INFORMATION Our internal management financial reporting consists of two…
- BF-A (Brown-Forman Corporation)
- (no filing in the citation store)
- BF-B (Brown-Forman Corporation)
- FY2025 10-K: …competing products. If the buying power of these large retail customers continues to increase, it could negatively affect our financial results. Further, while we believe we have sufficient scale to succeed relative to our major competitors, we nevertheless face a risk that continuing consolidation of large beverage…
- FY2025 10-K: …to distribute our brands, generally under fixed-term distribution contracts. In Canada, we sell our products to provincial governments. We believe that our customer relationships are good and that our exposure to concentrations of credit risk is limited due to the diverse geographic areas covered by our operations…
- CCEP (COCA-COLA EUROPACIFIC PARTNERS PLC)
- FY2025 20-F: …volume, comparable and FX neutral revenue and revenue per unit case, comparable and FX neutral operating profit, comparable diluted EPS, comparable free cash flow, ROIC and comparable ROIC are non-IFRS performance measures. Non-IFRS adjusted comparable financial information as if the acquisition of Coca-Cola…
- FY2025 20-F: Our performance indicators Reported revenue ♦ Reported operating profit Reported diluted earnings per share (EPS) Net cash flows from operating activities Return on invested capital (ROIC) €20.9bn €2.8bn €4.26 €3.0bn 10.9% Comparable and FX neutral revenue Comparable and FX neutral operating profit Comparable diluted…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
Diageo Aide Memoire FY Fiscal 2026, 10 July 2026 · company earnings calendar · Diageo Fiscal 26 Q3 Trading Statement, 6 May 2026 · company announcements, 11 May 2026 and 21 April 2026 · company announcements, 30 January 2026 and 25 March 2026